Swine-Origin-H1N.ppt

Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,*,Swine Origin H1N1 2009,Clinical Aspects,Javeed Siddiqui M.D.,M.P.H,Division of Infectious and Immunologic Diseases,Center for Health and Technology,School of Medicine,University of California,Davis,Clinical Case,September 2009,Clinical Case,Clinical Case,Clinical Case,Clinical Presentation,The symptoms of pandemic H1N1 influenza of 2009 are essentially the same as the seasonal flu,although some have noted,an increased frequency of gastrointestinal symptoms,including vomiting and diarrhea.,It has been noted some have observed the absence of fever in a significant number with virologically proven cases.,CDC.Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A(H1N1)virus infection.,June 2009.Available at:Accessed September 16,2009.,),S-OIV H1N1 Clinical Findings,Incubation:mean of 3-9 days Range 1-7 days,Symptoms:,Fever(90%),Cough(100%),Headache(60%),Diarrhea(30%),Shinde V et al NEJM May 7 2009,Symptoms in virologically confirmed cases,Cough(98%),Subjective fever(96%),Fatigue(89%),Headache(82%),Sore throat(82%),Abdominal pain(50%),Diarrhea(48%),Dyspnea(48%),Joint pain(46%),The measured mean peak fever in this group was 102.2 F.,During an outbreak of H1N1 in a New York City high school,a sample of New York City school students(median age,15 years)with virologically confirmed cases.,Accessed November 7,2009,MMWR Morb Mortal Wkly Rep Dispatch.,2009;58:1-3.,.,The CDC Definitions,influenza-like illness,(ILI),fever of 100 F(37.8 C)plus cough and/or sore throat in the absence of a known cause other than influenza.,acute respiratory illness,(ARI),defined by the presence of 2 of the following 4 symptoms:fever,cough,sore throat,or rhinorrhea.,Accessed November 7,2009,),Case Definitions for,S-OIV H1N1,Confirmed case:,Patient with ILI plus laboratory evidence confirmed by real-time RT-PCR or viral culture.,Probable case:,ILI plus laboratory test positive for influenza A and negative for human H1 and H3 by RT-PCR;and,Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A(H1N1)virus infection.June 2009.,Accessed November 7,2009.,Complications of S-OIV H1N1,Related Risk for Infection,Hospitalization,and Lethal Outcome,Age-related risk.,Rates for H1N1 for May-July 2009 by Age,AgeCases/100,000Hospitalization/100,000Death%,0-4 yrs234.57(2%)a,5-24 yrs272.148(16%),25-49 yrs71.1124(41%),50-64 yrs41.271(24%),65 yrs1.31.726(2%),a%of total deaths.Age data not available for 15%.,Rate expressed/100,000 population,US age data,(Novel Swine-Origin Influenza A(H1N1)Virus Investigation Team;Dawood FS,Jain S,Finelli L,et al.,Emergence of a novel swine-origin influenza A(H1N1)virus in humans.N Engl J Med.2009;360:2605-2,Severe complications of,S-OIV H1N1,In June 2009,the University of Michigan reported severe pulmonary complications of 2009 H1N1 influenza infection in 10 patients with a median age of 49 years.,All 10 patients were referred for severe hypoxemia,ARDS,and inability to oxygenate with conventional ventilation methods.All had severe multilobar pneumonia on x-ray,none had evidence of bacterial pneumonia,and 4 had CT scan-confirmed pulmonary embolism.,CDC.Intensive care patients with severe novel influenza A(H1N1)virus infection-Michigan,June,2009,.MMWR Morb Mortal Wkly Rep.,2009;58:749-752,),Severe complications of,S-OIV H1N1,Lab findings included leukocytosis in 5(median WBC 9500/mm,3,),elevated AST levels(41-109 IU/L)in all 10,and elevated CPK levels(51-6572 IU/L)in 6;none had evidence of disseminated intravascular coagulation.,CDC.Intensive care patients with severe novel influenza A(H1N1)virus infection-Michigan,June,2009,.MMWR Morb Mortal Wkly Rep.,2009;58:749-752,),Severe complications of,S-OIV H1N1,The major risk factor was obesity in 9 and morbid obesity(BMI 40)in 7.,All 10 required advanced mechanical ventilation with high-frequency oscillatory or bilevel ventilation with mean airway pressures of 32-55 cm H,2,O.,Two required veno-venous extracorporeal membrane oxygenation(ECMO)support and 6 required dialysis.,At the time of the report,3 had died,1 was still on ECMO,1 was still on mechanical ventilation,and 5 had been transferred back to referring institutions.,CDC.Intensive care patients with severe novel influenza A(H1N1)virus infection-Michigan,June,2009,.MMWR Morb Mortal Wkly Rep.,2009;58:749-752,),Neurologic complications,Neurologic complications were reported in 4 children ages 7-17 years with 2009 H1N1 influenza A.,Findings included seizures in 2 children,encephalitis in 2,and ataxia in 1.,All recovered without neurologic sequelae.,The editorial comment in this report noted that the neurologic disease in these 4 patients was less severe than what has been described in previous reports of seasonal flu.,CDC.Neurological complications associated with novel influenza A(H1N1)infection in children-Dallas,Texas,May 2009,.MMWR Morb Mortal Wkly Rep.,2009;58:773-778.;,Maricich SM,Neuf JL,Lotze TE,et al.Neurologic complications association with influenza A in children during the 2003-2004,influenza season in Houston,Texas,.Pediatrics.,2004;114:e626-e633.;,Morishima T,Togashi T,Yokota S,et al.Encephalitis and encephalopathy associated with an influenza epidemic in Japan.,Clin Infect Dis.,2002;35:512-517,.),Severe Cases,10 Cases across Michigan,BMI 30 for 9/10,All with high level rescue ventilation,MAP 32-55 cm H2O,6/10 CRRT,2/10 ECMO,3 deaths,Post:severe ALI with hemorrhage,MMWR July 17,2009/58(27);749-752,Risks for serious disease requiring hospitalization or causing death:Pregnancy and 2009 influenza A(H1N1),One hundred pregnant women with swine flu have been hospitalized in ICUs.,28 of these women have died,Pregnancy:A review of 34 confirmed cases of 2009 H1N1 influenza in pregnant women,reported to the CDC from 13 states,showed that 11 women were hospitalized and 6 died.,All 6 deaths were in previously healthy women who developed viral pneumonia and ARDS requiring mechanical ventilation.,None of the 5 infants born to these women had evidence of influenza.,CDC Press Briefing Transcripts.Weekly 2009 H1N1 Flu Media Briefing.October 1,2009.,Jamieson DJ,Honein MA,Rasmussen SA,et al.H1N1 2009 influenza virus infection during pregnancy in the USA.,Lancet.,2009;374:451-458.),Acute Respiratory Distress Syndrome and,S-OIV H1N1,The PB1-F2 protein of Influenza A virus:increasing pathogenicity by disrupting alveolar macrophages,J Robert Coleman,Virol J.2007;4:9.Published online 2007 January,Influenza A virus and the PB1-F2 protein,This protein,named PB1-F2,has an apoptotic induction effect on macrophages,thus reducing their ability to contribute to an immune response.,It has been previously suggested that this PB1-F2 protein contributes to viral pathogenicity solely because of it causes an inhibition of viral clearance,thus increasing cytoxicity.,Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1)Acute Respiratory Distress Syndrome,The Australia and New Zealand Extracorporeal Membrane Oxygenation(ANZ ECMO)Influenza Investigators,JAMA.2009;302(17):1888-1895.Published online October 12,2009,ARDS/ECMO and SO-H1N1,Main Outcome Measures:,Incidence,clinical features,degree of pulmonary dysfunction,technical characteristics,duration of ECMO,complications,and survival.,ARDS/ECMO and SO-H1N1,68 patients with severe influenza-associated ARDS were treated with ECMO,61 had either confirmed 2009 influenza A(H1N1)(n=53)or influenza A not subtyped(n=8),ARDS/ECMO and SO-H1N1,An additional 133 patients with influenza A received mechanical ventilation but no ECMO in the same ICUs.,ARDS/ECMO and SO-H1N1,The 68 patients who received ECMO had a median(interquartile range IQR)age of 34.4(26.6-43.1)years and 34 patients(50%)were men.,ARDS/ECMO and SO-H1N1,Before ECMO,patients had severe respiratory failure despite advanced mechanical ventilatory support with a median(IQR)PaO2/fraction of inspired oxygen(FIO2)ratio of 56(48-63),positive end-expiratory pressure of 18(15-20)cm H2O,an acute lung injury score of 3.8(3.5-4.0).,ARDS/ECMO and SO-H1N1,The median(IQR)duration of ECMO support was 10(7-15)days.,ARDS/ECMO and SO-H1N1,At the time of reporting,48 of the 68 patients(71%;,95%confidence interval CI,60%-82%),had survived to ICU discharge,32 had survived to hospital discharge and 16 remained as hospital inpatients,Fourteen patients(21%;,95%CI,11%-30%),had died and 6 remained in the ICU,2 of whom were still receiving ECMO,ARDS/ECMO and SO-H1N1,Conclusions:,During June to August 2009 in Australia and New Zealand,The ECMO-treated patients were often young adults with severe hypoxemia and had a 21%mortality rate at the end of the study period.,ARDS/ECMO and SO-H1N1,Affected patients were often young adults,pregnant or postpartum,obese,had severe respiratory failure before ECMO,and received prolonged mechanical ventilation and ECMO support,ARDS/ECMO and SO-H1N1,Despite their illness severity and the prolonged use of life support,most of these patients survived,This information should facilitate health care planning and clinical management for these complex patients during the ongoing pandemic.,Bacterial co-infections,Bacterial co-infections,CDC investigators reviewed clinical records and pathology reports from 77 lethal cases of pandemic H1N1 infection.,The tissue specimens were examined by tissue Gram stain,Warthin-Starry silver stain,various microbe-specific immunohistochemical assays,and PCR that targeted the 16S ribosomal DNA in tissue blocks.,Morens DS,Taubenberger JK,Fauci AS.Prominent role of bacterial pneumonia as a cause of death in pandemic influenza:,implications for pandemic influenza preparedness,J Infect Dis.2008;198:962-970,Bacterial co-infections,Bacteria were detected in 22 of 77 cases(29%),Streptococcus pneumoniae,(10),Staphylococcus aureus,(7),Streptococcus pyogenes,(6),Streptococcus mitis,(2),Haemophilus influenzae,(1),4 cases had more than 1 pathogen.,The study authors emphasize the importance of bacterial superinfection in patients with influenza.During the 1918-19 pandemic,most deaths were associated with bacterial superinfection.,Morens DS,Taubenberger JK,Fauci AS.Prominent role of bacterial pneumonia as a cause of death in pandemic influenza:,implications for pandemic influenza preparedness,J Infect Dis.2008;198:962-970,MRSA Post-influenza Pneumonia,Treatment and Prevention,Summary of Antiviral Resistance,U.S.2008-09,Influenza viruses,Antiviral,Seasonal A(H1N1),Seasonal A(H3N2),Seasonal B,Pandemic H1N1,Adamantanes,Susceptible,Resistant,No activity,Resistant,Oseltamivir,Resistant,Susceptible,Susceptible,Susceptible,Zanamivir,Susceptible,Susceptible,Susceptible,Susceptible,Oseltamivir-resistance among Pandemic H1N1 viruses,3 oseltamivir-resistant isolates of Pandemic H1N1 detected,-2 cases found to have resistant strain while on oseltamivir chemoprophylaxis,-Japan and Denmark,-1 case detected by Hong Kong Department of Health reported a resistant virus isolated from a 16 year-old girl who had a fever upon arrival at the Hong Kong International airport,-,Illness began prior to boarding the plane in San Francisco,-No exposure to,-No illness among close contacts,-,No sign of community transmission,-Al recovered uneventfully,No change in recommendations for treatment or prophylaxis of persons with influenza,Antiviral Treatment Recommendations,Priority:Hospitalized Patients with suspected or confirmed pandemic H1N1 virus infection,-Treatment recommended with Oseltamivir or Zanamivir,-Treat patients as soon as possible(duration:5 days),Antiviral Treatment Recommendations,Outpatients with suspected or confirmed pandemic H1N1 virus infection who are at high risk for complications,-Persons with chronic pulmonary,cardiac,renal,hepatic,metabolic,hematological disorders;immunosuppression,pregnant women,children 5 years;adults 65 years,-Treatment recommended with Oseltamivir or Zanamivir,-Treat patients as soon as possible(duration:5 days),Thank You,